BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 37998740)

  • 21. New directions in treating peripheral T-cell lymphomas (PTCL): leveraging epigenetic modifiers alone and in combination.
    Ma H; O'Connor OA; Marchi E
    Expert Rev Hematol; 2019 Mar; 12(3):137-146. PubMed ID: 30782038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist.
    Nicolae A; Pittaluga S; Venkataraman G; Vijnovich-Baron A; Xi L; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2013 Jun; 37(6):816-26. PubMed ID: 23598959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification.
    Fernandez-Pol S; Ma L; Joshi RP; Arber DA
    Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):416-422. PubMed ID: 29629950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.
    Leca J; Lemonnier F; Meydan C; Foox J; El Ghamrasni S; Mboumba DL; Duncan GS; Fortin J; Sakamoto T; Tobin C; Hodgson K; Haight J; Smith LK; Elia AJ; Butler D; Berger T; de Leval L; Mason CE; Melnick A; Gaulard P; Mak TW
    Cancer Cell; 2023 Feb; 41(2):323-339.e10. PubMed ID: 36736318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality.
    Krug A; Tari G; Saidane A; Gaulard P; Ricci JE; Lemonnier F; Verhoeyen E
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35625998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of follicular helper T cell markers in nodal peripheral T cell lymphomas: a tissue microarray analysis of 162 cases.
    Zhan HQ; Li XQ; Zhu XZ; Lu HF; Zhou XY; Chen Y
    J Clin Pathol; 2011 Apr; 64(4):319-24. PubMed ID: 21330314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas.
    Ye Y; Ding N; Mi L; Shi Y; Liu W; Song Y; Shu S; Zhu J
    Exp Hematol Oncol; 2021 Feb; 10(1):9. PubMed ID: 33546774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic Aberrations and Targets in Peripheral T-Cell Lymphoma.
    Atallah-Yunes SA; Robertson MJ; Davé UP
    Clin Lymphoma Myeloma Leuk; 2022 Sep; 22(9):659-665. PubMed ID: 35577752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of a 5 Marker Panel to the Routine Diagnosis of Peripheral T-Cell Lymphoma With T-Follicular Helper Phenotype.
    Basha BM; Bryant SC; Rech KL; Feldman AL; Vrana JA; Shi M; Reed KA; King RL
    Am J Surg Pathol; 2019 Sep; 43(9):1282-1290. PubMed ID: 31283630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma.
    Lee YP; Yoon SE; Cho J; Ko YH; Jo H; Kim SJ; Kim WS
    Ann Hematol; 2022 Jul; 101(7):1535-1543. PubMed ID: 35639152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathological and Molecular Features of Nodal Peripheral T-Cell Lymphomas.
    Satou A; Takahara T; Tsuzuki T
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent activating mutations of CD28 in peripheral T-cell lymphomas.
    Rohr J; Guo S; Huo J; Bouska A; Lachel C; Li Y; Simone PD; Zhang W; Gong Q; Wang C; Cannon A; Heavican T; Mottok A; Hung S; Rosenwald A; Gascoyne R; Fu K; Greiner TC; Weisenburger DD; Vose JM; Staudt LM; Xiao W; Borgstahl GE; Davis S; Steidl C; McKeithan T; Iqbal J; Chan WC
    Leukemia; 2016 May; 30(5):1062-70. PubMed ID: 26719098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.
    Palomero T; Couronné L; Khiabanian H; Kim MY; Ambesi-Impiombato A; Perez-Garcia A; Carpenter Z; Abate F; Allegretta M; Haydu JE; Jiang X; Lossos IS; Nicolas C; Balbin M; Bastard C; Bhagat G; Piris MA; Campo E; Bernard OA; Rabadan R; Ferrando AA
    Nat Genet; 2014 Feb; 46(2):166-70. PubMed ID: 24413734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frontline Management of Nodal Peripheral T-Cell Lymphomas.
    Ngu HS; Savage KJ
    Am Soc Clin Oncol Educ Book; 2023 May; 43():e390334. PubMed ID: 37262395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The new biology of PTCL-NOS and AITL: current status and future clinical impact.
    Timmins MA; Wagner SD; Ahearne MJ
    Br J Haematol; 2020 Apr; 189(1):54-66. PubMed ID: 32064593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.
    Wang C; McKeithan TW; Gong Q; Zhang W; Bouska A; Rosenwald A; Gascoyne RD; Wu X; Wang J; Muhammad Z; Jiang B; Rohr J; Cannon A; Steidl C; Fu K; Li Y; Hung S; Weisenburger DD; Greiner TC; Smith L; Ott G; Rogan EG; Staudt LM; Vose J; Iqbal J; Chan WC
    Blood; 2015 Oct; 126(15):1741-52. PubMed ID: 26268241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatment.
    Ahearne MJ; Allchin RL; Fox CP; Wagner SD
    Br J Haematol; 2014 Aug; 166(3):326-35. PubMed ID: 24815671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma.
    Maura F; Agnelli L; Leongamornlert D; Bolli N; Chan WC; Dodero A; Carniti C; Heavican TB; Pellegrinelli A; Pruneri G; Butler A; Bhosle SG; Chiappella A; Di Rocco A; Zinzani PL; Zaja F; Piva R; Inghirami G; Wang W; Palomero T; Iqbal J; Neri A; Campbell PJ; Corradini P
    Am J Hematol; 2019 Jun; 94(6):628-634. PubMed ID: 30829413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic abnormalities assist in pathological diagnosis and EBV-positive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients.
    Shi Y; Wang H; Liu Y; Long M; Ding N; Mi L; Lai Y; Zhou L; Diao X; Li X; Liu W; Zhu J
    Chin J Cancer Res; 2023 Oct; 35(5):536-549. PubMed ID: 37969960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological Study of 30 Cases of Peripheral T-cell Lymphoma with Hodgkin and Reed-Sternberg-like B-cells from Japan.
    Eladl AE; Satou A; Elsayed AA; Suzuki Y; Kato S; Asano N; Nakamura S
    Am J Surg Pathol; 2017 Apr; 41(4):506-516. PubMed ID: 28125450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.